More importantly, our data suggested that elevated expression of miR‐132‐3p, reduced expression of ZEB2, and increased cell proliferation were observed in lung cancer cells treated with DNA methyltransferase inhibitor. This evidence concerns the gene ZEB2 and lung carcinoma.